跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 36,151 条关于
“FGFR2/3”
全部
36,151
临床试验
17,863
药物
4,681
机构
1,356
资讯
12,251
5个月前
HARMONICARE Receives FDA Approval for FGFR2/3 Inhibitor ABSK061 Clinical Trial in Pediatric Achondroplasia
去年
Abbisko Cayman Initiates Phase II Trial of ABSK061 and ABSK043 for Advanced Solid Tumors
10个月前
Cogent Biosciences Unveils Promising KRAS Inhibitor Data with Superior Efficacy Profile
10个月前
Cogent Biosciences Raises $475.3 Million to Advance Bezuclastinib for Systemic Mastocytosis
21天前
Asieris Launches CEVIRA, World's First Non-Invasive Treatment for Precancerous Cervical Lesions
去年
Dual SHP2 and FGFR2 Inhibition Shows Promise in Treatment-Resistant Gastric Cancer
前天
HLB's Elevar Submits EMA Marketing Application for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma
前天
Elevar Submits EMA Marketing Authorization Application for Lirafugratinib in FGFR2-Fusion Cholangiocarcinoma
去年
Targeted Therapies Transform Biliary Tract Cancer Treatment Landscape with FGFR2 Inhibitors Leading Clinical Advances
去年
HUTCHMED Completes Enrollment for Phase II Registration Trial of Fanregratinib in FGFR2-Fusion Cholangiocarcinoma
第 1 页,共 1226 页
上一页
下一页